Skip to main content
Premium Trial:

Request an Annual Quote

CooperSurgical PGTai Technology Platform, ERPeak Endometrial Receptivity Test

CooperSurgical Fertility and Genomic Solutions has launched the CooperGenomics PGTai technology platform and the ERPeak endometrial receptivity test. Both will be available in North American from November 1 and internationally starting in January 2019.

The PGTai platform uses artificial intelligence and machine learning to improve the analysis, interpretation, and reporting of preimplantation genetic testing for aneuploidies (PGT-A). It is built on data from more than 1,000 biopsies that led to healthy babies. To validate the platform, the company analyzed sequencing data from more than 10,000 embryos and 5 million data points.

The ERPeak endometrial receptivity test detects the receptivity status of a woman's endometrium accurately and reliably. It measures the expression of several relevant hormone-regulated genes.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.